Based on our knockdown experiments and the usage of dominant-negative isoforms, we were able to identify Lef-1 as a positive and TCF4 as a negative regulator of PON2 expression in the CML cell line K562. Here, LEF1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.